HANDAYANI, F. (2025) “IMPACT OF THE COMBINATION OF DOXORUBICIN, CYCLOPHOSPHAMIDE, AND DOCETAXEL ON CA 15-3 BIOMARKER LEVELS IN BREAST CANCER PATIENTS: A COMPARATIVE STUDY BETWEEN DELAYED AND NON-DELAYED CHEMOTHERAPY”, International Journal of Applied Pharmaceutics, 17(1), pp. 82–88. doi: 10.22159/ijap.2025.v17s1.12.